A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment (Q44014994)
Jump to navigation
Jump to search
scientific article published in June 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment |
scientific article published in June 2002 |
Statements
1 reference
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment (English)
1 reference
Naomi N Bock
1 reference
Timothy R Sterling
1 reference
Carol D Hamilton
1 reference
Connie Pachucki
1 reference
Yong-Cheng Wang
1 reference
Donna S Conwell
1 reference
Ann Mosher
1 reference
Mary Samuels
1 reference
Andrew Vernon
1 reference
Tuberculosis Trials Consortium, Centers for Disease Control and Prevention, Atlanta, Georgia
1 reference
1 June 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference